CN201524332U - Bidirectional medicine inhaler - Google Patents

Abstract

The utility model relates to a bidirectional medicine inhaler, which comprises a tank body and a cover body; the tank body is provided with a cavity and a medicine outlet communicated with the cavity; the cover body is provided with a sleeve opening and a suction opening, a channel is formed between the sleeve opening and the suction opening, and the cover body can be selectively connected with the tank body through the sleeve opening or the suction opening so as to enable the channel to be communicated with the medicine outlet; therefore, the user can freely choose to use a bite-type or an embedding type to suck the atomized medicine in the inhaler according to the actual requirement of the user.

Description

bi-directional drug inhaler

technical field

The utility model relates to a medicament inhaler, in particular to a medicament inhaler which can freely choose to inhale atomized medicine in the inhaler by using a biting clip method or an embedded method.

Background technique

Modern epidemiology shows that more than 70% of human diseases are related to the environment. The most direct environmental impact on human health is the respiratory system. Respiratory diseases such as asthma are easily triggered by external environmental stimuli, causing patients to have difficulty breathing. Drugs such as bronchodilators or anti-inflammatory drugs are directly sent to the lungs to exert therapeutic effects, and the treatment of respiratory diseases by spraying has been proved by clinical experiments. The drug mist enters the bronchi through the mouth and nose, and then spreads to the entire alveoli. The effect is more efficient and direct than general oral medicines.

Inhalation therapy often uses a portable inhaler. Generally, the inhaler includes a cylinder with accommodating space and a high-pressure bottle mounted on the cylinder and filled with medicine. One end of the cylinder is provided with an inlet, and the other end is provided with a The outlet is located on the cylinder at the outlet end and is equipped with a mouthpiece for the patient to swallow, while the high-pressure bottle is installed at the entrance of the cylinder, and the high-pressure bottle is also provided with a conduit that can introduce medicine into the cylinder. Therefore, the medicine is sprayed into the accommodation space at a high speed and an atomization effect is generated at the same time. The patient holds the mouthpiece and inhales the atomized medicine through the outlet.

However, the patient must keep holding the mouthpiece in order to absorb the medicine mist in the holding space. After a period of time, the patient will easily feel muscle soreness. Bite the mouthpiece and cannot close it tightly, making it difficult to swallow the saliva. In addition, if the patient is a child, the child's bite force is weak and cannot bite the mouthpiece tightly, which will easily cause the medicine to leak out and be wasted. Less comfortable or less effective treatment procedures.

Utility model content

The purpose of this utility model is to provide a two-way usable drug inhaler, which can freely choose to use the biting clip method or the embedded method to inhale the atomized drug in the inhaler according to the actual needs of the user.

In order to achieve the above purpose, the utility model provides a bidirectionally usable drug inhaler, which is characterized in that it includes:

a tank having a chamber with a drug outlet communicating with the chamber; and

A cover body, one end has a mouth, the other end has a suction port, a channel is formed between the sleeve port and the suction port, the cover body can be selectively connected to the tank body with the sleeve end to make the channel communicate with the drug outlet or connect the tank with the suction port so that the channel communicates with the drug outlet.

The above-mentioned reversible medicament inhaler is characterized in that the tank body also has a medicament inlet communicating with the chamber.

The above-mentioned reversible medicament inhaler is characterized in that the radial length of the chamber gradually expands from the medicament inlet end to the medicament outlet end.

The above-mentioned bidirectionally usable drug inhaler is characterized in that the tank body is provided with a vent hole communicating with the chamber.

The above-mentioned reversible drug inhaler is characterized in that the radial length of the channel gradually expands from the mouthpiece end to the mouthpiece end.

The above-mentioned bidirectionally usable drug inhaler is characterized in that it further includes a tube connected to the cover.

The above-mentioned drug inhaler that can be used in two directions is characterized in that the tube body has an inserting portion passing through the mouthpiece end and a mouthpiece connected to the inserting portion.

The above-mentioned drug inhaler that can be used in both directions is characterized in that the tube body is opened with a tube communicating with the channel.

The effect of the utility model is that the patient can choose to connect the cover body to the tank body with the sleeve end, and the patient can bite the suction end with the mouth to absorb the atomized medicine in the channel and the chamber, or the patient can choose Connect the cover body to the tank body with the suction port, and the patient embeds the mouth into the sleeve port to absorb the nebulized medicine in the channel and the chamber. It is very comfortable to inhale the medicine mist by embedding and will not let the medicine mist The mist leaks out, but if the patient is not suitable to use the embedded suction method, they can still switch back to the bite clip suction method, which is very flexible.

The utility model will be described in detail below in conjunction with the accompanying drawings and specific embodiments, but not as a limitation of the utility model.

Description of drawings

Fig. 1 is the three-dimensional exploded view of the utility model;

Fig. 2 is the three-dimensional assembly drawing of the present utility model;

Fig. 3 is a sectional view along line 3-3 in Fig. 2;

Fig. 4 is one of combined schematic diagrams of another use state of the utility model;

Fig. 5 is the second combination schematic diagram of another use state of the utility model;

Fig. 6 is a sectional view of another usage state of the utility model;

Figure 7 is a three-dimensional combined view of Figure 6;

Fig. 8 is a combined sectional view of another embodiment of the present invention.

Among them, reference signs

Tank 10 Chamber 11

Drug Export 12 Drug Import 13

Cover body 20 sleeve mouth 21

Suction port 22 Channel 23

Pipe body 30 Socket part 31

Mouthpiece 32 Pipeline 33

Medicine storage bottle 40 Catheter 41

Detailed ways

The detailed description and technical content of the present utility model are described below with drawings, but the attached drawings are only for reference and illustration, and are not intended to limit the present utility model.

The utility model relates to a drug inhaler that can be used in two directions. Please refer to Figure 1 to Figure 3, which are the three-dimensional exploded view of the present utility model, the three-dimensional combination view of the present utility model, and the edge 3-3 in Figure 2 In the sectional view of the line, the bidirectionally usable drug inhaler includes a tank body 10 , a cover body 20 , and a tube body 30 .

The tank body 10 is roughly in the shape of a long tube, but not limited to this shape. The tank body 10 is hollow and forms a chamber 11 in the inner space. One end of the tank body 10 has a drug outlet 12. The tank body 10 The other end has a drug inlet 13, the drug outlet 12 and the drug inlet 13 communicate with the chamber 11, and the radial length of the chamber 11 gradually expands from the drug inlet 13 end toward the drug outlet 12 end, That is, the space shape of the chamber 11 is roughly conical, and a vent hole 14 communicated with the chamber 11 is opened on the side of the tank body 10 , and the vent hole 14 is located close to the drug inlet 13 .

The cover body 20 is roughly bowl-shaped, but not limited to this shape. One end of the cover body 20 has a mouth 21, and the other end of the cover body 20 has a suction port 22, and the diameter of the sleeve port 21 is larger than the suction port. 22, a passage 23 is formed between the sleeve mouth 21 and the suction mouth 22, and the radial length of the passage 23 gradually expands from the suction mouth 22 end toward the sleeve mouth 21 end so that the passage 23 has a bowl-like interval , the cover body 20 is connected to the drug outlet 12 of the tank body 10 with the socket 21 end so that the channel 23 communicates with the drug outlet 12, and the cover body 20 and the outer wall of the tank body 10 are connected to each other, so that the chamber 11 and the channel 23 are connected to the outside world by the drug inlet 13 and the suction port 22 .

The pipe body 30 has an inserting portion 31 and a mouthpiece 32 connected to the inserting portion 31. The inserting portion 31 is cylindrical, but not limited to this shape. The mouthpiece 32 is flat and rectangular. , but not limited to this shape, the pipe body 30 is provided with a pipe 33, the openings at both ends of the pipe 33 are respectively located at the insertion part 31 and the mouthpiece part 32, the pipe body 30 passes through the end of the suction port 22 to The insertion portion 31 is connected to the cover body 20 , so that the pipe 33 communicates with the channel 23 and the chamber 11 .

Please refer to Fig. 2 and Fig. 3, when in use, a medicine storage bottle 40 is passed through the medicine inlet 13, and the patient bites and clamps the mouthpiece 32 with the mouth, for further explanation, the medicine storage bottle 40 One end is connected with a conduit 41, and the other end of the conduit 41 is connected to the drug inlet 13. The drug is released in the drug storage bottle 40 and simultaneously produces an atomization effect to become a drug mist. The drug mist passes through the conduit 41 and the drug inlet 13 and sprayed into the chamber 11 at high speed, the tank body 10 is used as a buffer. If the sprayed drug mist directly impacts the oropharynx, it will be deposited in the oropharynx and cause side effects. After the drug mist enters the chamber 11, since the radial area of the chamber 11 gradually expands from the drug inlet 13 end to the drug outlet 12 end, according to Bernoulli's law in fluid mechanics, in a continuous fixed flow field Among them, when the cross-sectional area of the flow channel increases, the fluid flow rate will slow down, so the drug mist enters the gradually expanding chamber 11, and its speed will slow down, so as to achieve the buffering effect, and the slowed down drug mist will pass through the channel 23 and the pipeline 33 are discharged, and can be supplied to patients for absorption, so that the medicine mist enters the lungs to treat diseases, and will not be deposited in the oropharynx. However, the single mist production amount of the medicine storage bottle 40 is limited. If the patient Only absorbing the medicine mist in the chamber 11 will inevitably fail to allow the medicine mist to reach the lungs due to insufficient inhalation. Therefore, the vent hole 14 provides a hole for the outside air to enter, so that when the patient inhales the medicine mist, it is not enough. The inhalation volume can be supplemented by outside air, so that the medicine mist can reach the lungs.

Please refer to Figures 4 to 4, which are respectively one of the combination schematic diagrams of another use state of the present utility model, the second combination schematic diagram of another use state of the present utility model, the cross-sectional view of another use state of the present utility model, As shown in the three-dimensional combination diagram of the figure, patients can inhale the medicine mist in another way. First, remove the tube body 30 from the suction port 22 end, and then connect the cover of the tank body 10 with the sleeve port 21 end. Take off the body 20 (as shown in the figure), turn over 180° so that the end of the suction port 22 is aligned with the drug outlet 12 (as shown in the figure), and connect the end of the suction port 22 to the tank body 10 so that the channel 23 communicates with the drug outlet 12 ( As shown in the figure), and the outer wall of the cover body 20 and the tank body 10 is connected to each other, so that the communication port of the chamber 11 and the channel 23 to the outside world is the drug inlet 13 and the sleeve mouth 21, then the patient can put the The mouth is buried in the sleeve mouth 21, that is, the cover body 20 is used as a suction mask, so that the patient does not need to bite and clamp the mouthpiece 32 to cause muscle soreness, but only needs to bury the mouth in the mouthpiece. The medicine mist can be easily absorbed from the chamber 11 and the channel 23 in the sleeve 21 , which is very comfortable and does not allow the medicine mist to leak out.

Please refer to the figure, which is a combined cross-sectional view of another embodiment of the present utility model. The tank body 10 is roughly in the shape of an ellipse, and the cover body 20 is roughly in the shape of a thin-walled bowl and is attached to the tank body 10 in a cover-like manner. The suction port 22 communicates with the chamber 11 through the hemispherical surface on the drug outlet 12 side, and the tube body 30 is inserted into the chamber 11 through the suction port 22 .

Of course, the utility model can also have other various embodiments, and those skilled in the art can make various corresponding changes and deformations according to the utility model without departing from the spirit and essence of the utility model, but These corresponding changes and deformations should all belong to the protection scope of the appended claims of the present utility model.

Claims (8)

1. A bidirectionally usable drug inhaler, characterized in that it comprises: a tank having a chamber with a drug outlet communicating with the chamber; and A cover body, one end has a mouth, the other end has a suction port, a channel is formed between the sleeve port and the suction port, the cover body can be selectively connected to the tank body with the sleeve end to make the channel communicate with the drug outlet or connect the tank with the suction port so that the channel communicates with the drug outlet. 2. The bidirectionally usable drug inhaler according to claim 1, wherein the tank body further has a drug inlet communicating with the chamber. 3 . The bidirectionally usable drug inhaler according to claim 2 , wherein the radial length of the chamber gradually expands from the drug inlet end toward the drug outlet end. 4 . 4. The bidirectionally usable drug inhaler according to claim 1, characterized in that, the tank body is provided with a vent hole communicating with the chamber. 5 . The bidirectionally usable drug inhaler according to claim 1 , wherein the radial length of the channel gradually expands from the mouthpiece end to the mouthpiece end. 6 . 6 . The bidirectionally usable drug inhaler according to claim 1 , further comprising a tube passing through the cover. 7 . 7 . The bidirectionally usable drug inhaler according to claim 6 , wherein the tube body has an inserting portion connected to the mouthpiece end and a mouthpiece connected to the inserting portion. 8 . 8 . The bidirectionally usable drug inhaler according to claim 6 , characterized in that, the tube body is opened with a tube communicating with the channel.

Images